Landmark Genome Study Uncovers 57 Genetic Loci Linked to Stuttering

A large-scale genome-wide study involving 1.1 million individuals has made a breakthrough in understanding the genetic basis of stuttering. By analyzing data from genetic testing company 23andMe, researchers identified 57 DNA regions associated with stuttering—findings published in Nature Genetics. These genes are linked to brain function and rhythm perception, suggesting potential connections between stuttering and neurodevelopmental or psychiatric disorders such as autism and depression.

Stuttering affects roughly 1% of the global population, typically emerging in childhood. While some recover naturally, many continue to experience symptoms throughout life. Previous studies, constrained by technology, relied on small and isolated populations, limiting broader applicability. Leveraging large-scale genetic databases, scientists compared nearly 100,000 individuals with stuttering to 980,000 without, revealing that stuttering, like insomnia and type 2 diabetes, is a complex polygenic trait.

The most strongly associated gene, VRK2, is involved in neuronal development and has links to neurological disorders such as schizophrenia and epilepsy. It may also influence rhythm perception—a hypothesis further supported by research from the University of Michigan. Over 20 other identified genes overlap with autism and ADHD, suggesting shared neurodevelopmental pathways.

Experts at the University of Southern California emphasized that the findings reinforce stuttering as a neurological condition rather than a behavioral or psychological one, urging pediatricians to take family history into account. However, the study has limitations, including an overrepresentation of female participants and underrepresentation of African and Asian ancestry groups, warranting further validation in more diverse populations.